30 April 2013, London: College Hill Life Sciences, part of the international business communications consultancy College Group, announces that it has been selected as communications partner by Connect Digital Health, the organisers of the Digital Health Forum for Investors & Industry 2013 (DHF13), to be held at the Royal Society of Medicine, London on 11 June 2013.
DHF13 will host key executives from across the digital health ecosystem and will showcase the best ‘deal-ready’ digital health companies from around the world and facilitate meetings with potential investors and corporate partners from the pharmaceutical, biotechnology, medical device, big data, IT, software and hardware industries. Unlike most partnering conferences, DHF13 is designed to identify and attract investors and partnering companies with a specific and deep interest in the emerging digital health sector.
Commenting on College Hill's partnership with Connect Digital Health and DHF13, Sue Charles, Managing Partner, Life Sciences said:
“We have been building a considerable strength in the digital health space and are pleased to support DHF13 as an innovative venture at the intersection of healthcare, technology, biotech and pharma. We hope that the conference kick starts the development of a thriving and well-financed digital health ecosystem in the UK.”
College Hill is a leading international business communications consultancy with an exceptionally strong focus in the Mediscience sector. Its Life Sciences team is unique in that it has expertise across financial, corporate, healthcare and marketing communications, and integrates design into its communications mix. College Hill Life Sciences also offers seamless global outreach with teams located in the UK, Germany, Australia and the US. Its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit, academic organisations and science-associated bodies.
For further information:
Managing Partner, Life Sciences
+44 (0)20 7457 2020
Notes to Editors
About Connect Digital Health
Connect Digital Health (CDH) encourages entrepreneurship, promotes investment and nurtures industry collaborations focused on the development of digital tools that improve healthcare outcomes. CDH believes that the future of the digital health industry is predicated on improvement of healthcare outcomes. CDH’s goals are to help entrepreneurs realise potential, assist investors via a collaborative platform to develop opportunities and help large companies access innovation in addition to helping manage change in an industry experiencing this at an unprecedented speed. For more information please visit www.connectdigitalhealth.com.
Digital Health Forum for Investors & Industry 2013 (DHF13) showcases the best ‘deal-ready’ digital health companies from around the world and enables them to meet with potential investor and corporate partners from the pharmaceutical, biotechnology, medical device, big data, IT, software and hardware industries. This conference addresses the need to build new relationships and connections which are better suited to the rapidly changing healthcare landscape. For more information please visit www.dhf13.com.
Sue CharlesManaging Partner